Mesenchymal R-spondin 3 promotes an immunogenic tumor microenvironment with adaptive immune resistance in human gastric adenocarcinoma - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

R-spondin 3 from Mesenchymal Cells Enhances Immunogenicity and Adaptive Immune Resistance in Human Gastric Adenocarcinoma

  • By

  • Anne-Sophie Fischer

  • Alexander Arnold

  • Hilmar Berger

  • Stefanie Müllerke

  • Jonas Wizenty

  • Hans-Joachim Mollenkopf

  • David Horst

  • Frank Tacke

  • Christoph Treese

  • Michael Sigal

  • August 24, 2026

Share

Original Source(s)

Mesenchymal R-spondin 3 promotes an immunogenic tumor microenvironment with adaptive immune resistance in human gastric adenocarcinoma

  • by Anne-Sophie Fischer, Alexander Arnold, Hilmar Berger, Stefanie Müllerke, Jonas Wizenty, Hans-Joachim Mollenkopf, David Horst, Frank Tacke, Christoph Treese, Michael Sigal

  • August 24, 2026

Related Content

Sertoli cell tumor in familial adenomatous polyposis: a case report

Prognostic superiority of volumetric PET parameters (MTV and TLG) over SUV in advanced non-small-cell lung cancer: a systematic review and meta-analysis of univariate and multivariate evidence

Transitioning from hand-sewn to circular stapled cervical anastomosis after minimally invasive esophagectomy: a Western centre propensity score matching analysis